TBIO — Telesis Bio Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.07m
- $1.97m
- $27.51m
U.S. STOCKS ON THE MOVE-DXP Enterprises, Holley, Augmedix
U.S. STOCKS ON THE MOVE-Arlo Technologies, Old Republic, Clearmind Medicine
Telesis Bio falls after revenue miss
Brief: Telesis Bio Inc Q1 Revenue Rises 12.1%
Brief: Telesis Bio Reports First Quarter 2023 Financial Results
Brief: Telesis Bio Appointed Eric Esser As President
U.S. STOCKS ON THE MOVE-Carvana, Vistagen, Shoe Carnival
U.S. STOCKS ON THE MOVE-Warner Music, 89Bio, Ollie's
U.S. STOCKS ON THE MOVE-Virgin Orbit, Stratasys, US banks
Telesis Bio rises as revenue more than triples
Brief: Telesis Bio Reports Fourth Quarter Financial Results
Brief: Telesis Bio Releases BioXp® Select mRNA Synthesis Kit
Brief: Telesis Bio Says Q4 Revenue Rose 191 Percent To $9.0 Million
U.S. STOCKS ON THE MOVE-Wendy's, Corebridge, Riskified
U.S. STOCKS ON THE MOVE-Trade Desk, PolarityTE, Axon, Disney, Meta
U.S. STOCKS ON THE MOVE-Tesla, Canopy Growth, Merrimack Pharma
U.S. STOCKS ON THE MOVE-Novavax, Meta, Invitae
Telesis Bio gains on 2022 sales forecast raise
Codex DNA Inc reports results for the quarter ended in September - Earnings Summary